By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pluristem Therapeutics 

New York  New York    U.S.A.
Phone: n/a Fax: n/a



Company News
Pluristem Therapeutics (PSTI) & Charite Expand Cooperation Agreement To Include Orthopedic Indications 10/12/2015 7:20:06 AM
Pluristem Therapeutics (PSTI) CEO Zami Aberman Elected To Board Of Directors Of The Alliance For Regenerative Medicine 10/7/2015 11:40:46 AM
Pluristem Therapeutics (PSTI) and National Institute of Allergy And Infectious Diseases (NIAID) Complete FDA Meeting on PLX-R18 Cells in ARS 9/21/2015 6:25:40 AM
Pluristem Therapeutics (PSTI) Completed Successful Meeting With The U.S. FDA In Preparation For Filing An IND For PLX-R18 To Treat Incomplete Hematopoietic Recovery After Bone Marrow Transplantation 9/9/2015 7:38:44 AM
Pluristem Therapeutics (PSTI) President Yaky Yanay Elected As Co-Chairman Of Israel Advanced Technology Industries 9/8/2015 7:53:18 AM
Pluristem Therapeutics (PSTI) Granted U.S. Patent For Production Methods And Use Of Placental Cell Therapy In A Range Of Indications 8/17/2015 6:08:28 AM
Japan Grants Safety Clearance To Pluristem Therapeutics (PSTI)'s PLX-PAD Cells For Use In Clinical Trials 8/12/2015 8:12:21 AM
Pluristem Therapeutics (PSTI) In Key Discussions With Europe's Adaptive Pathways Group On Phase II Protocol In Critical Limb Ischemia 8/10/2015 7:41:34 AM
New Data Show Pluristem Therapeutics (PSTI)s PLX Cells Regulate The Immune System 7/27/2015 7:42:42 AM
Pluristem Therapeutics (PSTI) Announces Pricing Of Registered Direct Offering Of Common Stock And Warrants 6/25/2015 7:54:24 AM